Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 September 2007

Thorax. Published Online First: 27 March 2007. doi:10.1136/thx.2006.072041
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Airway responsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects

Fawzia Runa Ali 1, Anthony Barrington Kay 1* and Mark Larche 2

1 Imperial College London, United Kingdom
2 McMaster University, Canada

* To whom correspondence should be addressed. E-mail: j.m.mitchell{at}imperial.ac.uk.

Accepted 6 February 2007


Abstract

Background: Allergic asthmatics develop isolated late asthmatic reactions after inhalation of allergen- derived T-cell peptides. Animal experiments have shown that airway hyperresponsiveness is CD4+ cell-dependent. We hypothesise that peptide inhalation produces increases in non-specific airway hyperresponsiveness (AHR) and a T-cell dominant, bronchial mucosal inflammatory response.

Methods: Bronchoscopy, with bronchial biopsies and bronchoalveolar lavage (BAL), was performed in 24 cat-allergic subjects 6 hours after aerosol inhalation of short overlapping peptides derived from Fel d 1, the major cat allergen. Biopsies and BAL were studied using immunohistochemistry and ELISA.

Results: Twelve of the 24 subjects developed an isolated late asthmatic reaction without a preceding early- (mast cell/histamine-dependent) reaction characteristic of whole allergen inhalation. These responders had a significant between-group differences (responders vs non-responders) in the changes (peptide vs diluent) in AHR (p= 0.007) and bronchial mucosal CD3+ (p=0.005), CD4+ (p=0.006) and TARC+ (p=0.003) but not CD8+ or CD25+ cells or eosinophils, basophils, mast cells and macrophages. The between-group difference for neutrophils was p=0.05 but with a non-significant within group value (peptide vs diluent, responders, p=0.11). In BAL there was a significant between-group difference in TARC (p=0.02) but not in histamine, tryptase, basogranulin, C3a or C5a, LTC4/D4/E4, PGD2 or PGF2{alpha}.

Conclusions: Direct activation of allergen- specific airway T cells by peptide inhalation in atopic asthmatics leads to increased airway hyperresponsiveness with local increases in CD3+ and CD4+ cells and TARC but no significant changes in eosinophils or basophil/mast cell products thereby supporting previous animal experiments which showed a CD4+ dependence for airway hyperresponsiveness.

Keywords: T cells, airway hyperresponsiveness, cytokines, late asthmatic reactions, peptides


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2007 62: e745. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs